Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics
Dose-finding clinical trial in China designed to evaluate safetyand preliminary anti-tumor activity of SN301A (SENTI-301A manufactured in ...
Q&A: Improving liver cancer outcomes through enhanced immunotherapy
Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at ...
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas ...
Pharmaceutical Technology23h
Risk adjusted net present value: What is the current valuation of Bristol-Myers Squibb’s Adakitug?
Adakitug is a monoclonal antibody commercialized by Bristol-Myers Squibb, with a leading Phase II program in Solid Tumor.
PGI accounts for most organ transplants in Pb, Hry & HP
Chandigarh: Punjab, Haryana (excluding NCR), and Himachal Pradesh recorded a total of 221 organ transplants from Aug to Nov this year, a 20% increase .
CMAJ7h
Cost–benefit analysis of Canada’s Prison Needle Exchange Program for the prevention of hepatitis C and injection-related infections
Background: Needle exchange programs are effective public health interventions that reduce blood-borne infections, including ...